These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 2063598

  • 1. [The effect of oral trapidil therapy on clinical and hemorheological parameters in arteriosclerosis obliterans in comparison to pentoxifylline--a pilot study].
    Regenthal R, Voigt H, Reuter W, Preiss R.
    Z Gesamte Inn Med; 1991 Apr; 46(6):185-90. PubMed ID: 2063598
    [Abstract] [Full Text] [Related]

  • 2. [Oral trapidil treatment of Fontaine stage II arteriosclerotic circulatory disorders of the legs--a double-blind study].
    Voigt H, Reuter W, Hofmann B, Dobberkau A.
    Z Gesamte Inn Med; 1990 May 15; 45(10):283-7. PubMed ID: 2392858
    [Abstract] [Full Text] [Related]

  • 3. [Lipid metabolism and peripheral hemodynamics in arteriosclerosis obliterans treated with nifedipine--a comparison with pentoxifylline].
    Beykirch H, Reuter W, Voigt H, Herrmann W.
    Z Gesamte Inn Med; 1989 Feb 01; 44(3):77-9. PubMed ID: 2728555
    [Abstract] [Full Text] [Related]

  • 4. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK, Chopra KL, Aggarwal KK, Parashar SK.
    Indian Heart J; 1989 Feb 01; 41(2):127-33. PubMed ID: 2744799
    [Abstract] [Full Text] [Related]

  • 5. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK, Chopra KL, Aggarwal KK, Parashar SK.
    J Med; 1988 Feb 01; 19(2):89-107. PubMed ID: 3049876
    [Abstract] [Full Text] [Related]

  • 6. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
    Reilly DT, Quinton DN, Barrie WW.
    N Z Med J; 1987 Jul 22; 100(828):445-7. PubMed ID: 3330188
    [Abstract] [Full Text] [Related]

  • 7. [Serum lipid levels in patients with arteriosclerosis obliterans of the legs during treatment with pentoxifylline].
    Kuczyńska K, Zebrowski M, Kancelarczyk WL, Rymaszewski Z.
    Pol Tyg Lek; 1988 Aug 22; 43(34):1092-4. PubMed ID: 3075031
    [No Abstract] [Full Text] [Related]

  • 8. [Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical plasma components in patients with occlusive arteriosclerosis of the lower limbs].
    Turczyński B, Sroczyński J, Antoszewski Z, Matyszczyk B, Krupa G, Grzegorczyn S.
    Pol Tyg Lek; 1988 Aug 22; 46(37-39):700-3. PubMed ID: 1669136
    [Abstract] [Full Text] [Related]

  • 9. [Effect of long-term pentoxifylline treatment on selected parameters of the fibrinolytic system in patients with arteriosclerosis obliterans of the legs].
    Berent H, Kancelarczyk WL, Zebrowski M, Uchman B.
    Pol Tyg Lek; 1988 Jun 13; 43(24):776-8. PubMed ID: 3237518
    [No Abstract] [Full Text] [Related]

  • 10. Effects of pentoxifylline administration on blood viscosity and leukocyte cytoskeletal function in patients with intermittent claudication.
    Rao KM, Simel DL, Cohen HJ, Crawford J, Currie MS.
    J Lab Clin Med; 1990 Jun 13; 115(6):738-44. PubMed ID: 2366034
    [Abstract] [Full Text] [Related]

  • 11. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
    Duthois S, Cailleux N, Lévesque H.
    J Mal Vasc; 2000 Feb 13; 25(1):17-26. PubMed ID: 10705132
    [Abstract] [Full Text] [Related]

  • 12. Results of clinical, laboratory and haemorheological investigations of the use of pentoxifylline in high doses.
    Antignani PL, Todini AR, Saliceti F, Pacino G, Bartolo M.
    Pharmatherapeutica; 1987 Feb 13; 5(1):50-6. PubMed ID: 3602022
    [Abstract] [Full Text] [Related]

  • 13. Pentoxifylline (Trental) has no significant effect on laboratory parameters in sickle cell disease.
    Billett HH, Kaul DK, Connel MM, Fabry ME, Nagel RL.
    Nouv Rev Fr Hematol (1978); 1989 Feb 13; 31(6):403-7. PubMed ID: 2694097
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic defibrinogenation by ancrod: effect on limb blood flow in peripheral vascular disease.
    Wiles PG, Nelson SR, Hampton KK, Casali B, Boothby M, Prentice CR.
    Blood Coagul Fibrinolysis; 1990 Oct 13; 1(4-5):385-8. PubMed ID: 2133215
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical components in patients with diabetes type II and ischemia of the lower extremities].
    Turczyński B, Sroczyński J, Antoszewski Z, Matyszczyk B, Krupa G, Młynarski J, Strugala M.
    Pol Tyg Lek; 1990 Oct 13; 46(37-39):708-10. PubMed ID: 1669138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.